CHINOOK THERAPEUTICS, INC. - FORM 10-K - EX-23.1 - EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - March 8, 2016

Attached files

file filename
EX-21.1 - EX-21.1 SUBSIDIARIES OF REGISTRANT. - CHINOOK THERAPEUTICS, INC.adro-ex211_453.htm
EX-31.2 - EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. - CHINOOK THERAPEUTICS, INC.adro-ex312_313.htm
EX-10.41 - EX-10.41 AMENDMENT TO RESEARCH AND LICENSE AGREEMENTS BETWEEN ADURO BIOTECH, INC. AND JANSSEN BIOTECH, INC. DATED NOVEMBER 11, 2015. - CHINOOK THERAPEUTICS, INC.adro-ex1041_683.htm
EX-32.1 - EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER, AS REQUIRED BY RULES 13A-14(A) AND 15D-14(A) AND SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE (18 U.S.C. 1350). - CHINOOK THERAPEUTICS, INC.adro-ex321_311.htm
10-K - 10-K - CHINOOK THERAPEUTICS, INC.adro-10k_20151231.htm
EX-31.1 - EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. - CHINOOK THERAPEUTICS, INC.adro-ex311_314.htm

 

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-203508 on Form S-8 our report dated March 8, 2016, relating to the consolidated financial statements of Aduro Biotech, Inc. (the “Company”) appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2015.

 

/s/ DELOITTE & TOUCHE

San Francisco, California

March 8, 2016

 

CHINOOK THERAPEUTICS, INC. Reports